Mometasone Furoate Market Trends

Growth Drivers

• Growing interest in research and development activities - The rising mometasone furoate-related research and development efforts are anticipated to propel mometasone furoate market expansion. According to a report in 2021, one of the most important components of treatment for patients with eosinophilic esophagitis is topical corticosteroids.
  
  In addition, the purpose of this study was to examine the benefit of utilizing mometasone furoate spray versus placebo on dysphagia and health-related quality of life in these patients.

• Surge in new product launches - In 2020, Enerzair Breezhaler (QVM149; indacaterol acetate, glycopyrronium bromide, and mometasone furoate [IND/GLY/MF]) was approved by the European Commission (EC) to treat adult patients with asthma who have not had their asthma adequately controlled with a maintenance regimen that includes a long-acting beta2 agonist (LABA) and a high-dose inhaled corticosteroid (ICS) and who have had one or more asthma exacerbations in the preceding year.
• Rising cases of respiratory allergies - Respiratory allergies can be caused by many irritants, like smoke and fumes, in both indoor and outdoor environments, which can fuel allergy symptoms or several allergic reactions.
  
  In the immune system, mometasone lessens the appearance of redness, swelling, and itching, which are signs of allergic reactions and inflammatory diseases. The patient’s nose's puffiness and mucous are reduced with the nasal spray. Although the effects last longer than those of antihistamine sprays, it may take a little longer to start working. Therefore, the growing prevalence of respiratory allergies globally is also accelerating mometasone furoate market share.

Challenges

• Exposure to piracy and corruption - The sector faces a serious threat from some of the common side effects of mometasone, such as allergic reactions, nausea, vomiting, loss of appetite, headaches, and many more. On the other hand, some severe side effects that may negatively impact the growth of the revenue share are crusting, blurry vision or vision loss, and white patches in the nose or mouth. These problems cause barriers for the users, which slows down the mometasone furoate market share.

• High competition from alternative drugs may hamper the growth of the landscape.

• The market revenue for mometasone furoate is further hampered by strict regulatory requirements and approval processes.